[Federal Register Volume 85, Number 58 (Wednesday, March 25, 2020)]
[Notices]
[Page 16945]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06249]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC); 
Cancellation of Meeting

    Notice is hereby given of a change in the meeting of the Clinical 
Laboratory Improvement Advisory Committee (CLIAC); April 16, 2020, 8:30 
a.m. to 5:00 p.m., EDT and April 17, 2020, 8:30 a.m. to 11:30 a.m., 
EDT, in the original FRN. Food and Drug Administration (FDA), White Oak 
Campus, 10903 New Hampshire Avenue, Building 31, Great Room, Silver 
Spring, Maryland 20993 and via webcast at www.cdc.gov/cliac which was 
published in the Federal Register on February 28, 2020, Volume 85, 
Number 40, page 11993.
    This meeting is being canceled in its entirety.

FOR FURTHER INFORMATION CONTACT: Nancy Anderson, MMSc, MT(ASCP), Senior 
Advisor for Clinical Laboratories, Division of Laboratory Systems, 
Center for Surveillance, Epidemiology and Laboratory Services, Office 
of Public Health Scientific Services, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE, Mailstop V24-3, Atlanta, Georgia 
30329-4027, telephone (404) 498-2741; [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-06249 Filed 3-24-20; 8:45 am]
BILLING CODE 4163-18-P